136 related articles for article (PubMed ID: 19175331)
1. Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells.
Yin N; Long X; Goff RD; Zhou D; Cantu C; Mattner J; Mezard PS; Teyton L; Bendelac A; Savage PB
ACS Chem Biol; 2009 Mar; 4(3):199-208. PubMed ID: 19175331
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor effects by chemical modified IGb3 analogues.
Zhou Z; Zhang C; Xia C; Chen W; Zhu H; Shang P; Ma F; Wang PG; Zhang J; Xu W; Tian Z
Mol Cancer Ther; 2011 Aug; 10(8):1375-84. PubMed ID: 21653685
[TBL] [Abstract][Full Text] [Related]
3. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells.
Xia C; Schümann J; Emmanuel R; Zhang Y; Chen W; Zhang W; De Libero G; Wang PG
J Med Chem; 2007 Jul; 50(15):3489-96. PubMed ID: 17608465
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.
Chen W; Xia C; Wang J; Thapa P; Li Y; Talukdar A; Nadas J; Zhang W; Zhou D; Wang PG
J Org Chem; 2007 Dec; 72(26):9914-23. PubMed ID: 18020363
[TBL] [Abstract][Full Text] [Related]
5. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
[TBL] [Abstract][Full Text] [Related]
6. Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells.
Xia C; Zhou D; Liu C; Lou Y; Yao Q; Zhang W; Wang PG
Org Lett; 2006 Nov; 8(24):5493-6. PubMed ID: 17107055
[TBL] [Abstract][Full Text] [Related]
7. CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells.
Sanderson JP; Brennan PJ; Mansour S; Matulis G; Patel O; Lissin N; Godfrey DI; Kawahara K; Zähringer U; Rossjohn J; Brenner MB; Gadola SD
Eur J Immunol; 2013 Mar; 43(3):815-25. PubMed ID: 23280365
[TBL] [Abstract][Full Text] [Related]
8. A divergent approach to the synthesis of iGb3 sugar and lipid analogues via a lactosyl 2-azido-sphingosine intermediate.
Cheng JM; Dangerfield EM; Timmer MS; Stocker BL
Org Biomol Chem; 2014 May; 12(17):2729-36. PubMed ID: 24652424
[TBL] [Abstract][Full Text] [Related]
9. Chemical modification of iGb3 increases IFN-gamma production by hepatic NKT cells.
Shang P; Zhang C; Xia C; Chen W; Han Q; Wang PG; Zhang J; Tian Z
Int Immunopharmacol; 2008 May; 8(5):645-53. PubMed ID: 18387506
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic synthesis of Gb3 and iGb3 ceramides.
Adlercreutz D; Weadge JT; Petersen BO; Duus JØ; Dovichi NJ; Palcic MM
Carbohydr Res; 2010 Jul; 345(10):1384-8. PubMed ID: 20206917
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells.
Yu ED; Girardi E; Wang J; Zajonc DM
J Immunol; 2011 Sep; 187(5):2079-83. PubMed ID: 21810611
[TBL] [Abstract][Full Text] [Related]
12. [Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].
Porubsky S; Luckow B; Bonrouhi M; Speak A; Cerundolo V; Platt F; Gröne HJ
Pathologe; 2008 Nov; 29 Suppl 2():297-302. PubMed ID: 18810447
[TBL] [Abstract][Full Text] [Related]
13. Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.
Porubsky S; Speak AO; Salio M; Jennemann R; Bonrouhi M; Zafarulla R; Singh Y; Dyson J; Luckow B; Lehuen A; Malle E; Müthing J; Platt FM; Cerundolo V; Gröne HJ
J Immunol; 2012 Sep; 189(6):3007-17. PubMed ID: 22875802
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal glycosphingolipid recognition by NKT cells.
Zhou D; Mattner J; Cantu C; Schrantz N; Yin N; Gao Y; Sagiv Y; Hudspeth K; Wu YP; Yamashita T; Teneberg S; Wang D; Proia RL; Levery SB; Savage PB; Teyton L; Bendelac A
Science; 2004 Dec; 306(5702):1786-9. PubMed ID: 15539565
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids.
Zajonc DM; Savage PB; Bendelac A; Wilson IA; Teyton L
J Mol Biol; 2008 Apr; 377(4):1104-16. PubMed ID: 18295796
[TBL] [Abstract][Full Text] [Related]
16. Chewing the fat on natural killer T cell development.
Godfrey DI; McConville MJ; Pellicci DG
J Exp Med; 2006 Oct; 203(10):2229-32. PubMed ID: 17000869
[TBL] [Abstract][Full Text] [Related]
17. Chemoenzymatic syntheses of iGb3 and Gb3.
Yao Q; Song J; Xia C; Zhang W; Wang PG
Org Lett; 2006 Mar; 8(5):911-4. PubMed ID: 16494472
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
[TBL] [Abstract][Full Text] [Related]
19. Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.
Liu X; Zhang P; Zhang Y; Wang Z; Xu S; Li Y; Huai W; Zhou Q; Chen X; Chen X; Li N; Wang P; Li Y; Cao X
Cell Res; 2019 Jan; 29(1):42-53. PubMed ID: 30514903
[TBL] [Abstract][Full Text] [Related]
20. Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry.
Li Y; Zhou D; Xia C; Wang PG; Levery SB
Glycobiology; 2008 Feb; 18(2):166-76. PubMed ID: 18048405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
